Plasana Medical develops a compact cold plasma device for non‑invasive treatment of chronic wounds such as venous leg ulcers and diabetic foot ulcers. The technology stimulates tissue regeneration and provides antiseptic action, reducing infection risk and hospital stays. It is intended for use by healthcare professionals in hospitals and home care settings.
Funding
Funding not disclosed
Founders
Product
Problem
Chronic wounds such as venous leg ulcers and diabetic foot ulcers require prolonged treatment periods, often exceeding 200 days, and are prone to infection and repeated hospitalizations. The lengthy healing process imposes a significant burden on patients and health‑care systems alike. Current therapeutic options are frequently invasive or lack consistent antiseptic efficacy.
Solution
Plasana Médical offers a compact, handheld cold‑plasma device that delivers non‑thermal, dielectric‑barrier discharge to the wound surface. The plasma stream generates reactive species that stimulate cellular proliferation, angiogenesis, and extracellular matrix remodeling while providing a broad‑spectrum antiseptic effect. The system is designed for point‑of‑care use by clinicians in hospitals, outpatient clinics, and home‑health settings, requiring minimal training and no consumable gases. Integrated safety controls automatically limit temperature and exposure time, ensuring painless application. Data from each treatment session can be logged to a secure cloud portal for longitudinal tracking and outcome analysis. By accelerating closure and reducing infection risk, the device aims to improve patient quality of life and lower overall health‑care expenditures.
Target Audience
The primary customers are wound‑care specialists, podiatrists, vascular surgeons, and home‑health agencies that manage chronic leg and foot ulcers. The device is also suitable for hospital wound‑care units and outpatient clinics seeking a non‑invasive, antiseptic treatment option.
Features
- Dielectric‑barrier discharge (DBD) cold‑plasma generator producing reactive oxygen and nitrogen species at ≤40 °C
- Adjustable plasma power and pulse duration to match wound depth and tissue type
- Ergonomic, lightweight handheld unit with battery operation for true mobility
- Disposable, single‑use applicator tip with built‑in sterility indicator
- Real‑time temperature and impedance monitoring with automatic shut‑off safeguards
- CE‑marked medical device complying with IEC 60601‑1 electrical safety standards
- Integrated Bluetooth connectivity for automatic upload of treatment parameters to a HIPAA‑compliant cloud dashboard
- User‑friendly touchscreen interface guiding clinicians through protocol steps and documenting session data